| scholarly article | Q13442814 |
| P2093 | author name string | Etty N Benveniste | |
| Hongwei Qin | |||
| Xiangyu Ma | |||
| Xingang Li | |||
| Brandi J Baker | |||
| Stephanie L Reynolds | |||
| P2860 | cites work | Neuroscience: Glia — more than just brain glue | Q22337266 |
| Molecular dissection of reactive astrogliosis and glial scar formation | Q24646628 | ||
| Structure and signalling in the IL-17 receptor family | Q24648045 | ||
| The astrocyte odyssey | Q24654727 | ||
| Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer | Q24677026 | ||
| Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis | Q24681662 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| IL-17 and Th17 Cells | Q27860566 | ||
| CBP/p300 in cell growth, transformation, and development | Q28140313 | ||
| Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras | Q28186689 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Cutting edge: interleukin 17 signals through a heteromeric receptor complex | Q28247130 | ||
| Interleukin-17 and type 17 helper T cells | Q28256510 | ||
| TH17 cells in development: an updated view of their molecular identity and genetic programming | Q28276449 | ||
| Interleukin-17 family members and inflammation | Q28287876 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Induction and regulation of interleukin-6 gene expression in rat astrocytes | Q28580235 | ||
| IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
| Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression | Q33383235 | ||
| SOCS1 and SOCS3 in the control of CNS immunity | Q33717795 | ||
| Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes | Q33717808 | ||
| Interleukin-6 expression and regulation in astrocytes | Q33850723 | ||
| SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation | Q33958723 | ||
| Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori | Q34049840 | ||
| An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. | Q34290234 | ||
| Immune function of astrocytes | Q34398643 | ||
| Molecular biology. Chromatin higher order folding--wrapping up transcription | Q34849091 | ||
| Interleukin-6 and chronic inflammation | Q35578869 | ||
| Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease | Q36228235 | ||
| Interleukin-6 trans-signalling in chronic inflammation and cancer | Q36460931 | ||
| T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
| SOCS proteins, cytokine signalling and immune regulation | Q36831668 | ||
| Astrocytes--friends or foes in multiple sclerosis? | Q36878427 | ||
| Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. | Q36970752 | ||
| Glial regulation of the cerebral microvasculature | Q36983682 | ||
| IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice | Q37036086 | ||
| Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes | Q37052050 | ||
| Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis | Q37210991 | ||
| Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells | Q37366068 | ||
| The roles of IL-17A in inflammatory immune responses and host defense against pathogens | Q37374929 | ||
| SOCS3 negatively regulates IL-6 signaling in vivo | Q38354512 | ||
| The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma | Q39814307 | ||
| TGF-beta promotes Th17 cell development through inhibition of SOCS3. | Q39950912 | ||
| Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. | Q40065423 | ||
| IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia | Q40298466 | ||
| Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells | Q40502827 | ||
| Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. | Q40946726 | ||
| IL-17 enhances chemokine gene expression through mRNA stabilization | Q42824985 | ||
| Differential regulation of chemokines by IL-17 in colonic epithelial cells | Q44384488 | ||
| Mixed results with modulation of TH-17 cells in human autoimmune diseases | Q46204430 | ||
| Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. | Q48853057 | ||
| Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. | Q51948116 | ||
| Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. | Q55473999 | ||
| IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway | Q57705959 | ||
| Differential modulation of astrocyte cytokine gene expression by TGF-beta | Q72813001 | ||
| An array of possibilities for multiple sclerosis | Q78029079 | ||
| IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3 | Q79370187 | ||
| IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis | Q79755041 | ||
| Adverse functions of IL-17A in experimental sepsis | Q80771020 | ||
| Interleukin-17 in transverse myelitis and multiple sclerosis | Q81097713 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | astrocyte | Q502961 |
| P304 | page(s) | 4898-4906 | |
| P577 | publication date | 2010-03-29 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | IL-17 enhancement of the IL-6 signaling cascade in astrocytes | |
| P478 | volume | 184 |
| Q36557095 | A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation |
| Q37075106 | AMP-activated protein kinase restricts IFN-γ signaling. |
| Q36852167 | Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells. |
| Q34612600 | Astrocytes protect neurons against methylmercury via ATP/P2Y(1) receptor-mediated pathways in astrocytes |
| Q37061583 | Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice |
| Q37117337 | Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses |
| Q34611991 | CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia |
| Q89896570 | Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role |
| Q35047326 | Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. |
| Q35606563 | Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis |
| Q90049756 | Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury |
| Q34238642 | Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense |
| Q42379262 | Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties |
| Q35780674 | Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury |
| Q34325082 | Expression of suppressor of cytokine signaling-3 (SOCS3) and its role in neuronal death after complete spinal cord injury |
| Q88712306 | Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV |
| Q38802501 | Gene regulation and genetics in neurochemistry, past to future. |
| Q39560205 | Grape seed proanthocyanidin extract inhibits interleukin-17-induced interleukin-6 production via MAPK pathway in human pulmonary epithelial cells |
| Q37873072 | How do immune cells overcome the blood-brain barrier in multiple sclerosis? |
| Q35209789 | Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses |
| Q36086895 | IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain |
| Q36694535 | IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells |
| Q37865163 | IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease |
| Q40231889 | IL-17-triggered downregulation of miR-497 results in high HIF-1α expression and consequent IL-1β and IL-6 production by astrocytes in EAE mice |
| Q54340434 | IL-17A induces MIP-1α expression in primary astrocytes via Src/MAPK/PI3K/NF-kB pathways: implications for multiple sclerosis. |
| Q57807449 | IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway |
| Q42925515 | IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis |
| Q35134651 | IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals. |
| Q51035936 | Identification of IL-17A-derived neural cell type and dynamic changes of IL-17A in serum/CSF of mice with ischemic stroke. |
| Q38118936 | Immune players in the CNS: the astrocyte |
| Q64056647 | Immunity Against Bacterial Infection of the Central Nervous System: An Astrocyte Perspective |
| Q93047629 | Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6 |
| Q36058899 | Interaction of astrocytes and T cells in physiological and pathological conditions |
| Q36650270 | Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway |
| Q89550757 | Interleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner |
| Q38058511 | Interleukin-6, a major cytokine in the central nervous system |
| Q41295048 | Lack of IL-6 increases blood-brain barrier permeability in fungal meningitis |
| Q39271108 | Maternal IL-17A in autism |
| Q37574101 | Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism |
| Q27011014 | Multiple sclerosis: the role of cytokines in pathogenesis and in therapies |
| Q37297056 | NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma |
| Q28565232 | Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation |
| Q36428502 | Non-alcoholic fatty liver disease induces signs of Alzheimer's disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model |
| Q34297966 | PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. |
| Q28485407 | Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3 |
| Q98176768 | Psychiatric face of COVID-19 |
| Q83410295 | Regulation of CCL20 expression in astrocytes by IL-6 and IL-17 |
| Q34058953 | Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection |
| Q34287544 | SOCS3 deficiency promotes M1 macrophage polarization and inflammation. |
| Q36338274 | Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome |
| Q39926107 | Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia |
| Q38469322 | T Cells-Protective or Pathogenic in Alzheimer's Disease? |
| Q37000362 | TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina |
| Q48204335 | The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis. |
| Q58123198 | The Neuro-Immuno-Senescence Integrative Model (NISIM) on the Negative Association Between Parasympathetic Activity and Cellular Senescence |
| Q92106859 | The Role of Epigenetics in Autoimmune/Inflammatory Disease |
| Q91584710 | The core genes involved in the promotion of depression in patients with ovarian cancer |
| Q44270195 | The interleukin 17 system in cortical lesions in focal cortical dysplasias |
| Q62178506 | The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes |
| Q35613323 | Therapeutic potential of AZD1480 for the treatment of human glioblastoma |
| Q90676826 | Δ9-Tetrahydrocannabinol (THC) Impairs CD8+ T Cell-Mediated Activation of Astrocytes |
Search more.